First PCSK9 Inhibitor Approved for Blanket Prevention of Heart Disease

(MedPage Today) — The PCSK9 inhibitor evolocumab (Repatha) got the FDA’s blessing for cardiovascular protection, with or without a history of cardiovascular disease (CVD).
Evolocumab is now indicated for the wider pool of adults at increased…

Source link : https://www.medpagetoday.com/cardiology/dyslipidemia/117148

Author :

Publish date : 2025-08-25 20:36:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

First PCSK9 Inhibitor Approved for Blanket Prevention of Heart Disease

Hyperbaric Chamber Explosions Prompt FDA Letter to Doctors

Potent Cannabis Products Linked to Psychosis, Mental Health Risks

Related Posts

3D-printed electronics can dissolve in water for quick recycling

Risk of Malignant Tumor Rises After Traumatic Brain Injury

Study Examines Off-Target Mortality in Cancer Screening

Low-Cal Mediterranean Diet Plus Exercise Linked to Less Diabetes Onset

Expect Health Insurance Prices to Rise Next Year, Brokers and Experts Say

Potent Cannabis Products Linked to Psychosis, Mental Health Risks

3D-printed electronics can dissolve in water for quick recycling

Risk of Malignant Tumor Rises After Traumatic Brain Injury

Study Examines Off-Target Mortality in Cancer Screening

Low-Cal Mediterranean Diet Plus Exercise Linked to Less Diabetes Onset

Expect Health Insurance Prices to Rise Next Year, Brokers and Experts Say

Potent Cannabis Products Linked to Psychosis, Mental Health Risks

Just How Long Should RA Patients Be Checked for Drug Toxicity?

Very Abnormal Results Rare in DMARD Toxicity Monitoring

Categories

Archives